TC Scientific Inc.: federal grants and contributions: 5 agreements; $1.7M value; 3 departments; 3 programs.
Assay record ASY-CA-1HWL983120 · Cite as: Assay Systems, “TC Scientific Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/tc-scientific-inc/
Expand development and manufacturing of advanced pharmaceuticals - Budget 2021
This collaborative project between AC Pharmaceuticals Co., Ltd. in the city of Guangzhou, Guangdong Province, China and TC Scientific Inc. in Edmonton, Alberta, Canada, is to develop lenalidomide sustained-release tablets for the treatment of myelodysplastic syndromes (MDS). TC Scientific Inc. will develop new synthetic routes for lenalidomide and a production process that will be substantially less expensive to execute. The new process will avoid use of strong oxidizing agents and expensive reagents and will also reduce the generation of toxic waste by using less toxic reagents. Consequentl
Develop digital adoption plan
All grants from Innovation, Science and Economic Development Canada
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.